150 related articles for article (PubMed ID: 36635515)
21. Prediction of distant metastases in patients with squamous cell carcinoma of head and neck using DWI and DCE-MRI.
Chawla S; Kim SG; Loevner LA; Wang S; Mohan S; Lin A; Poptani H
Head Neck; 2020 Nov; 42(11):3295-3306. PubMed ID: 32737951
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
Chawla S; Kim S; Dougherty L; Wang S; Loevner LA; Quon H; Poptani H
AJR Am J Roentgenol; 2013 Jan; 200(1):35-43. PubMed ID: 23255739
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
[TBL] [Abstract][Full Text] [Related]
24. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
Tezcan S; Ozturk FU; Uslu N; Akcay EY
Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
[TBL] [Abstract][Full Text] [Related]
25. Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI.
Sun B; Song L; Wang X; Li J; Xian J; Wang F; Tan P
J Magn Reson Imaging; 2017 May; 45(5):1438-1445. PubMed ID: 27649521
[TBL] [Abstract][Full Text] [Related]
26. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
[TBL] [Abstract][Full Text] [Related]
27. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
Kul S; Metin Y; Bekircavusoglu S; Kul M
Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
[TBL] [Abstract][Full Text] [Related]
28. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.
Kul S; Cansu A; Alhan E; Dinc H; Gunes G; Reis A
AJR Am J Roentgenol; 2011 Jan; 196(1):210-7. PubMed ID: 21178069
[TBL] [Abstract][Full Text] [Related]
29. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
30. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
[TBL] [Abstract][Full Text] [Related]
32. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
34. Dynamic Contrast-Enhanced MRI in the Evaluation of Carotid Space Paraganglioma versus Schwannoma.
Gaddikeri S; Hippe DS; Anzai Y
J Neuroimaging; 2016 Nov; 26(6):618-625. PubMed ID: 27102237
[TBL] [Abstract][Full Text] [Related]
35. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
36. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
37. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
38. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
39. Skull metastases and osseous venous malformations: The role of diffusion-weighted and dynamic contrast-enhanced MRI.
Kurokawa R; Kurokawa M; Holmes A; Baba A; Bapuraj J; Capizzano A; Kim J; Srinivasan A; Moritani T
J Neuroimaging; 2022 Nov; 32(6):1170-1176. PubMed ID: 35922879
[TBL] [Abstract][Full Text] [Related]
40. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
